Tag: Accord healthcare

Pregabalin, the active ingredient in Pregabalin Accord, is an anticonvulsant that was initially approved in 2004 by the FDA for its anti-epileptic effects. So, what is Pregabalin Accord used for? It is now commonly prescribed for a range of conditions, including various forms of neuropathic pain, generalized anxiety disorder, and as an adjunct therapy for partial seizures.

Affecting millions with hypothyroidism, the stability of levothyroxine is critical for patient health. A primary reason for recent instances where patients asked, 'Why was there a recall on levothyroxine?' relates to the medication's sensitive nature, which can cause its active ingredient to degrade over time, a problem known as subpotency.

In July 2025, the U.S. Food and Drug Administration (FDA) upgraded a significant recall involving more than 160,000 bottles of Levothyroxine Sodium, clarifying the answer to the question, "**What thyroid medicine is being recalled?**". This was classified as a Class II recall, indicating the product may cause temporary or medically reversible adverse health consequences.

In May 2025, the U.S. Food and Drug Administration (FDA) issued a Class II recall for specific lots of levothyroxine sodium tablets from Accord Healthcare due to subpotency. This was one of several actions taken throughout 2025 concerning thyroid medication manufactured by Intas Pharmaceuticals for Accord Healthcare.

As of September 2025, there are active recalls for specific batches of levothyroxine sodium tablets, with actions taken by manufacturers like Accord Healthcare and Pfizer. These recalls primarily cite subpotency, meaning the medication's active ingredient is below the labeled specification.

In July 2025, the U.S. Food and Drug Administration (FDA) upgraded a recall of Accord Healthcare's levothyroxine sodium tablets, impacting hundreds of thousands of bottles. This action prompts the urgent question: **Is levothyroxine being recalled in 2025?** Yes, several recalls have occurred this year, primarily due to the medication being less potent than labeled.

Medication-assisted treatment (MAT) is a proven, evidence-based approach that can increase the chances of long-term recovery for those with opioid use disorder (OUD). So, **what is the W22 pill used for?** It is a sublingual tablet containing buprenorphine and naloxone, prescribed to help manage opioid dependence by reducing cravings and suppressing withdrawal symptoms.